---

Market Overview

---

The global human identification market is projected to reach $6.44 billion by 2032, growing at a CAGR of 14.77% during the forecast period 2022-2032. This growth is attributed to the increasing adoption of Next-Generation Sequencing (NGS) in various research fields, the high adoption of forensic applications, and technological advancements in molecular techniques and diagnostic tests.

Human identification plays a crucial role in forensics, paternity testing, disaster victim identification, and anthropology, with DNA analysis/profiling being a key tool in this sector. However, human identification and forensics labs face the challenge of increasing efficiency without compromising quality due to the growing demands on time and resources. DNA and fingerprints are the preferred methods of identification, but they require a prior record and verifiable baseline for comparison. Advancements in genomics, proteomics, molecular biology, data analytics, and technical engineering have led to the development of advanced NGS-based technologies such as SNP and STR sequencing. Research on molecular technologies and biomarkers using NGS has also paved the way for significant procedures like mtDNA sequencing. The demand for non-invasive diagnostic procedures for genetic profiling has further propelled the need for NGS technologies. Biotechnology companies like Illumina, Inc., Thermo Fisher Scientific, and Agilent Technologies, Inc. have made substantial investments to support further developments in forensic technologies, acknowledging the future growth potential of non-invasive diagnostic procedures.

The increasing demand for human identification products and technologies is expected to drive the growth of the global human identification market during the forecast period 2022-2032. Factors such as the high adoption of forensic applications in computational biology and technological advancements in molecular techniques and diagnostic tests contribute to the significant growth rate of the market.

The COVID-19 pandemic has impacted the human identification market to some extent. The shutdowns and reduced capacity of laboratories and research institutions have led to a decrease in the usage of research-related products and services. The government-imposed restrictions, such as travel bans and business shutdowns, have increased the cost of COVID-19-related services and created operational and production challenges. However, the market related to COVID-19, especially testing services, has experienced growth. Overall, the impact of the pandemic on the market size has been moderate, with some players reporting a slight decline in sales. The market is already on its way to recovery, overcoming the initial disruptions caused by complete lockdowns and supply chain interruptions in 2020. The pandemic has indirectly contributed to improving the market’s growth outlook for human identification.

The demand drivers for the human identification market include the increasing demand for human identification products and technologies, high adoption of forensic applications in computational biology, and technological advancements in molecular techniques and forensic tests. However, the market also faces limitations such as the lack of forensic testing infrastructure and high capital requirements that hinder the expansion of global reach.

---

Market Segmentation

---

The market is segmented based on various factors, including offering, technology, application, end user, and region.

Segmentation by Offering
Product
Service

Segmentation by Technology
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Capillary Electrophoresis
Nucleic Acid Extraction and Purification (Magnetic Bead Technology)
Rapid DNA Analysis
Other Technologies

Segmentation by Application
Forensic Application
Paternity Identification
Other Applications

Segmentation by End User
Forensic Laboratories and Law Enforcement Agencies
Academic and Research Institutions
Hospitals and Healthcare Providers

Segmentation by Region
North America
Europe
Asia-Pacific
Latin America
Rest-of-the-World

In 2021, the service segment held the largest market share, accounting for 55.47% of the global human identification market. This trend is expected to continue until 2032, with the service segment projected to hold a 53.00% share. The significant share of the service segment can be attributed to the increasing demand for human identification services in paternity testing procedures, the rise in product launches and approvals, and the growing emphasis on adopting human identification technologies.

For example, in July 2021, Thermo Fisher Scientific Inc. announced that its Applied Biosystems RapidHIT ID DNA Booking System received approval from the Federal Bureau of Investigation (FBI). This system enables booking stations to automatically process, upload, and search DNA reference samples from qualifying arrestees against the U.S. National DNA Index System (NDIS) CODIS database.

PCR dominated the global human identification market by technology in 2021, capturing a significant market share of 41.00%. This trend is expected to continue until 2032, with PCR anticipated to hold a 37.11% market share. The dominance of PCR is primarily driven by the increasing incidences of violent crimes, leading to a higher demand for rapid DNA analysis technology in forensics testing.

Among all applications, the forensic segment held the largest market share in 2021, accounting for 61.88% of the market. This trend is expected to continue, with the paternity identification segment projected to hold a 33.00% share in 2032. The growth of forensic testing worldwide will contribute significantly to the expansion of this market.

In terms of end users, forensic laboratories and law enforcement agencies accounted for the largest market share in 2021, with a 67.04% share. This trend is expected to persist, with academic and research institutions projected to hold a 19.88% market share in 2032. Increasing global research activities will drive the growth of this market segment.

The North America region is expected to dominate the global human identification market from 2022 to 2032 due to its high adoption rate of forensic testing kits and services. The United States, in particular, exhibits both market share dominance and growth. During the forecast period, North America is projected to reach $3,526.7 million, with a compound annual growth rate (CAGR) of 15.07%. The region’s strong position is supported by increased awareness of paternity testing and a surge in demand for ancestry testing, especially in Europe and North America.

The Asia-Pacific region is expected to experience the highest CAGR of 17.48% during the forecast period. Factors such as an increase in violent crime cases and sexual assault cases, alongside a steady economy and a focus on genomic research, contribute to the region’s growth.

---

Recent Industry Developments

---

In 2021, QIAGEN established a strategic partnership with Verogen, Inc. with the objective of delivering high-quality tools and comprehensive support for forensic biometric identification workflows in laboratory settings.

In 2021, QIAGEN introduced the EZ2 Connect Instrument Line, a product lineup designed to accelerate the advantages of biomedical research, forensics, and clinical diagnostics.

In 2022, Promega Corporation unveiled the Spectrum CE System, a state-of-the-art solution developed specifically for conducting human identification in criminal casework and database cases within forensic laboratories.